Novo’s Wegovy pill tracks over 26,000 prescriptions
Jan 30 (Reuters) – Novo Nordisk’s Wegovy pill hits over 26,000 U.S. prescriptions in the second full week…
US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
Ozempic Brings Back the ‘Mac vs PC’ Ads for the GLP-1 Era
Novo Nordisk’s Ozempic kicked off the GLP-1 craze when it launched in 2018 for the treatment of Type…
How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?
Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its…
Health Canada approves 1st GLP-1 daily pill. Here’s who can take it – National
Health Canada has approved a GLP-1 pill for the first time. The once-a-day semaglutide pill is approved for…
Weight loss drug Wegovy to be listed on PBS
Wegovy will be heavily subsidised for Australians with severe obesity, who have also experienced a cardiovascular event, like…
Companies can make generic Ozempic as of next week, but don’t expect to get it soon
TORONTO — Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug…
Where Will Pfizer Be in 5 Years?
Pfizer’s stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…